20/20 Biolabs, Inc. (AIDX)
0.8669
-0.08
(-8.75%)
USD |
NASDAQ |
May 29, 16:00
0.879
+0.01
(+1.40%)
After-Hours: 20:00
20/20 Biolabs Total Liabilities (Quarterly) : 3.046M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 62.26M |
| Intelligent Bio Solutions, Inc. | 6.112M |
| Anteris Technologies Global Corp. | 16.31M |
| FONAR Corp. | 54.77M |
| Quest Diagnostics, Inc. | 8.928B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.803M |
| Shareholders Equity (Quarterly) | 2.757M |
| Debt to Equity Ratio | 0.3357 |
| Current Ratio | 1.822 |
| Net Debt Paydown Yield | 0.40% |